GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

In the new study, the Italian researchers recruited 132,986 adults aged 50 and older - 12,000 of who were hospitalised with a ...

Rating upgraded from 66 to 73 Tuesday — a welcome improvement, but still shy of the 80 or better score you prefer to see.

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

GSK’s Blenrep is the only B-cell maturation antigen (BCMA)-targeted antibody-drug conjugate for multiple myeloma, offering ...

Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Blood-based proteomic profiling of 251 inflammatory proteins in 543 patients with newly diagnosed acute myeloid leukemia (AML) identifies an eight-protein signature that enhances risk stratification.

This FTSE 100 firm's smaller than rivals but could benefit from its big US manufacturing footprint and competitive market ...

The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on June ...